Polymeric immunoglobulin receptor down-regulation in chronic obstructive pulmonary disease: Persistence in the cultured epithelium and role of transforming growth factor-β

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 5, 2014, Pages 509-521

  Gohy, Sophie T ^a,b   Detry, Bruno R ^a   Lecocq, Marylène ^a   Bouzin, Caroline ^a   Weynand, Birgit A ^c   Amatngalim, Gimano D ^d   Sibille, Yves M ^a   Pilette, Charles ^a,b,e  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Welbio (Walloon Excellence in Lifesciences and Biotechnology)   (Belgium)

Author keywords

Chronic obstructive pulmonary disease; IgA; Immunology

Indexed keywords

IMMUNOGLOBULIN A; SECRETORY COMPONENT; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BRONCHUS MUCOSA; CELL CULTURE; CELL DEDIFFERENTIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCYTOSIS; BRONCHUS; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT MUCOSA; SEVERITY OF ILLNESS INDEX; SMOKING; TISSUE CULTURE TECHNIQUE; UPREGULATION;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; IGA; IMMUNOLOGY;

AGED; BIOLOGICAL MARKERS; BRONCHI; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, POLYMERIC IMMUNOGLOBULIN; RESPIRATORY MUCOSA; SEVERITY OF ILLNESS INDEX; SMOKING; TISSUE CULTURE TECHNIQUES; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84908137637     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201311-1971OC     Document Type: Article

References (43)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Diagnosis, Management, and Prevention of COPD [updated 2014; accessed 2014]. Available from: http://www.goldcopd.org
2. Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:228-237.
3. Pilette C, Durham SR, Vaerman JP, Sibille Y. Lung mucosal immunity: a role for immunoglobulin A? Proceedings of the ATS 2004;1:125-135.
4. Pilette C, Godding V, Kiss R, Delos M, Verbeken E, Decaestecker C, De Paepe K, Vaerman JP, Decramer M, Sibille Y. Reduced epithelial expression of secretory component in small airways correlates with air flow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:185-194.
5. Pilette C, Ouadrhiri Y, Dimanche F, Vaerman JP, Sibille Y. Secretory component is cleaved by neutrophil serine proteinases but its epithelial production is increased by neutrophils through NF-kappa Band p38 mitogen-activated protein kinase-dependent mechanisms. Am J Respir Cell Mol Biol 2003;28:485-498.
6. Ratajczak C, Guisset A, Detry B, Sibille Y, Pilette C. Dual effect of neutrophils on pIgR/secretory component production by human bronchial epithelial cells: role of TGF-beta. J Biomed Biotechnol 2010;2010:42868.
7. Polosukhin VV, Cates JM, Lawson WE, Zaynagetdinov R, Milstone AP, Massion PP, Ocak S, Ware LB, Lee JW, Bowler RP, et al. Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;184:317-327.
8. Johansen FE, Kaetzel CS. Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal Immunol 2011;4:598-602.
9. Cao AT, Yao S, Gong B, Elson CO, Cong Y. Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis. J Immunol 2012;189:4666-4673.
10. Gohy S, Detry B, Bouzin C, Weynand B, Lecocq M, Sibille Y, Pilette C. Polymeric immunoglobulin receptor expression is downregulated in severe COPD: role of TGF-β1. Presented at the Munich Lung Conference 2013. October 4-5, 2013, Munich, Germany. ID39.
11. Puchelle E, Zahm JM, Tournier JM, Coraux C. Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006;3:726-733.
12. Beisswenger C, Platz J, Seifart C, Vogelmeier C, Bals R. Exposure of differentiated airway epithelial cells to volatile smoke in vitro. Respiration 2004;71:402-409.
13. Konsti J, Lundin M, Joensuu H, Lehtimäki T, Sihto H, Holli K, Turpeenniemi-Hujanen T, Kataja V, Sailas L, Isola J, et al. Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer. BMC Clin Pathol 2011;11:3.
14. Bustin SA, Benes V, Garson J, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley G, et al. The need for transparency and good practices in the qPCR literature. Nat Methods 2013;10:1063-1067.
15. Ocak S, Pedchenko TV, Chen H, Harris FT, Qian J, Polosukhin V, Pilette C, Sibille Y, Gonzalez AL, Massion PP. Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis. Eur Respir J 2012;39:1171-1180.
16. Hupin C, Rombaux P, Bowen H, Gould H, Lecocq M, Pilette C. Downregulation of polymeric immunoglobulin receptor and secretory IgA antibodies in eosinophilic upper airway diseases. Allergy 2013;68:1589-1597.
17. Ohlmeier S, Mazur W, Linja-Aho A, Louhelainen N, Rönty M, Toljamo T, Bergmann U, Kinnula VL. Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD. J Proteome Res 2012;11:599-608.
18. Rusznak C, Sapsford RJ, Devalia JL, Wang JH, Shah SS, Mills PR, Davies RJ, Lozewicz S. Cigarette smoke decreases the expression of secretory component in human bronchial epithelial cells, in vitro. Acta Microbiol Immunol Hung 2001;48:81-94.
19. Shi W, Chen F, Cardoso WV. Mechanisms of lung development: contribution to adult lung disease and relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009;6:558-563.
20. Fernandez IE, Eickelberg O. The impact of TGF-β on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc 2012;9:111-116.
21. Aubert JD, Dalal BI, Bai TR, Roberts CR, Hayashi S, Hogg JC. Transforming growth factor beta 1 gene expression in human airways. Thorax 1994;49:225-232.
22. Vignola AM, Chanez P, Chiappara G, Merendino A, Pace E, Rizzo A, la Rocca AM, Bellia V, Bonsignore G, Bousquet J. Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997;156:591-599.
23. de Boer WI, van Schadewijk A, Sont JK, Sharma HS, Stolk J, Hiemstra PS, van Krieken JH. Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:1951-1957.
24. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, Okada Y, Yamasawa F, Nakahara K, Umeda A. Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 2001;163:1476-1483.
25. Wang IM, Stepaniants S, Boie Y, Mortimer JR, Kennedy B, Elliott M, Hayashi S, Loy L, Coulter S, Cervino S, et al. Gene expression profiling in patients with chronic obstructive pulmonary disease and lung cancer. Am J Respir Crit Care Med 2008;177:402-411.
26. Ning W, Lee J, Kaminski N, Feghali-Bostwick CA, Watkins SC, Pilewski JM, Peters DG, Hogg JC, Choi AM. Comprehensive analysis of gene expression on GOLD-2 versus GOLD-0 smokers reveals novel genes important in the pathogenesis of COPD. Proc Am Thorac Soc 2006;3:466.
27. Doerner AM, Zuraw BL. TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids. Respir Res 2009;10:100.
28. Buckley ST, Medina C, Ehrhardt C. Differential susceptibility to epithelial-mesenchymal transition (EMT) of alveolar, bronchial and intestinal epithelial cells in vitro and the effect of angiotensin II receptor inhibition. Cell Tissue Res 2010;342:39-51.
29. Boxall C, Holgate ST, Davies DE. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir J 2006;27:208-229.
30. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol 2007;120:1233-1244, quiz 1245-1246.
31. Pierrou S, Broberg P, O'Donnell RA, Pawłowski K, Virtala R, Lindqvist E, Richter A, Wilson SJ, Angco G, Möller S, et al. Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:577-586.
32. Comer DM, Kidney JC, Ennis M, Elborn JS. Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers. Eur Respir J 2013;41:1058-1067.
33. Gras D, Bourdin A, Vachier I, de Senneville L, Bonnans C, Chanez P. An ex vivo model of severe asthma using reconstituted human bronchial epithelium. J Allergy Clin Immunol 2012;129:1259-1266.e1.
34. Lopez-Guisa JM, Powers C, File D, Cochrane E, Jimenez N, Debley JS. Airway epithelial cells from asthmatic children differentially express proremodeling factors. J Allergy Clin Immunol 2012;129:990-997, e6.
35. Churg A, Tai H, Coulthard T, Wang R, Wright JL. Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Am J Respir Crit Care Med 2006;174:1327-1334.
36. Wang RD, Wright JL, Churg A. Transforming growth factor-beta1 drives airway remodeling in cigarette smoke-exposed tracheal explants. Am J Respir Cell Mol Biol 2005;33:387-393.
37. Königshoff M, Kneidinger N, Eickelberg O. TGF-beta signaling in COPD: deciphering genetic and cellular susceptibilities for future therapeutic regimen. Swiss Med Wkly 2009;139:554-563.
38. Castaldi PJ, Cho MH, Cohn M, Langerman F, Moran S, Tarragona N, Moukhachen H, Venugopal R, Hasimja D, Kao E, et al . The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum Mol Genet 2010;19:526-534.
39. Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 2006;28:219-242.
40. Podowski M, Calvi C, Metzger S, Misono K, Poonyagariyagorn H, Lopez-Mercado A, Ku T, Lauer T, McGrath-Morrow S, Berger A, et al. Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice. J Clin Invest 2012;122:229-240.
41. Webb DR. Selective IgA deficiency and chronic obstructive pulmonary disease-a family study. Adv Exp Med Biol 1974;45:437-439.
42. Murphy TF, Lesse AJ, Kirkham C, Zhong H, Sethi S, Munson RS Jr. A clonal group of nontypeable Haemophilus influenzae with two IgA proteases is adapted to infection in chronic obstructive pulmonary disease. PLoS ONE 2011;6:e25923.
43. Millares L, Marin A, Garcia-Aymerich J, Sauleda J, Belda J, Monsó E; PAC-COPD Study Group. Specific IgA and metalloproteinase activity in bronchial secretions from stable chronic obstructive pulmonary disease patients colonized by Haemophilus influenzae. Respir Res 2012;13:113.